Critical Behavior and Magnetocaloric Simulation in LSMO/NaF Composites Using Landau Theory
Advanced Theory and Simulations · 2026-03 · 9 (3)
DOI: 10.1002/adts.202501677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Theory and Simulations, online erschienen am 10.12.2025. Verfasst von Mohamed Hsini und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben.
Abstract (Originalsprache)
The critical behavior of (1−x) LSMO/xNaF composites with x = 0, 0.05, 0.15, and 0.20 near the second‐order paramagnetic–ferromagnetic transition is investigated through a combination of Arrott–Noakes formalism (ANF) and Kouvel–Fisher (KF) analysis. Critical exponents ( β , γ ) are determined iteratively to be (1.0004, 0.3406), (1.1593, 0.6230), (1.0467, 0.4391), and (1.0479, 0.4673) for (1‐x)LSMO/xNaF with x = 0, 0.05, 0.15, and 0.20, respectively. Furthermore, magnetocaloric entropy changes , computed via Landau theory, exhibited strong correspondence with Maxwell relation results, with minor discrepancies at high fields attributed to saturation effects. Overall, the results highlight the robustness of Landau phenomenology in describing criticality and magnetocaloric behavior, while revealing subtle doping‐induced modifications in exchange interactions.
Zitieren
APA
Hsini, M., Zaidi, N., & Haouas, A. (2026). Critical Behavior and Magnetocaloric Simulation in LSMO/NaF Composites Using Landau Theory. Advanced Theory and Simulations, 9(3). https://doi.org/10.1002/adts.202501677
Vancouver
Hsini M, Zaidi N, Haouas A. Critical Behavior and Magnetocaloric Simulation in LSMO/NaF Composites Using Landau Theory. Advanced Theory and Simulations. 2026;9(3). doi:10.1002/adts.202501677
BibTeX
@article{Hsini2026,
author = {Hsini, Mohamed and Zaidi, Nadia and Haouas, Amel},
title = {Critical Behavior and Magnetocaloric Simulation in LSMO/NaF Composites Using Landau Theory},
journal = {Advanced Theory and Simulations},
year = {2026},
volume = {9},
number = {3},
doi = {10.1002/adts.202501677}
}
EUVIMED